Disease | non-alcoholic fatty liver disease |
Comorbidity | C0006142|breast cancer |
Sentences | 2 |
PubMedID- 26448028 | Selective estrogen receptor modulator-associated nonalcoholic fatty liver disease improved survival in patients with breast cancer: a retrospective cohort analysis. |
PubMedID- 24603540 | Thus, prevention and treatment of nafld in breast cancer patients require the elucidation of the mechanism of tam-induced nafld. |
Page: 1